Showing results (151-160 of 453) with videos related to

Sort By:
Pageof 46
Nature Reviews. Clinical Oncology|February 20, 2024
Targeting ATR in patients with cancerNatalie Y L Ngoi, Patrick G Pilié, Daniel J McGrail, et al.
Nature Reviews. Drug Discovery|July 23, 2016
Drug discovery in advanced prostate cancer: translating biology into therapyTimothy A Yap, Alan D Smith, Roberta Ferraldeschi, et al.
Current Opinion in Pharmacology|August 30, 2008
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promisesTimothy A Yap, Michelle D Garrett, Mike I Walton, et al.
Discovery Medicine|January 1, 2015
Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndromeRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
The Oncologist|June 5, 2024
Metastatic extraneural glioblastoma diagnosed with molecular testingNazanin K Majd, Henry Hiep Vo, Cesar A Moran, et al.
The Oncologist|March 30, 2018
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid TumorsGerald Edelman, Jordi Rodon, Joanne Lager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric CancerFunda Meric-Bernstam, Amber M Johnson, Ecaterina E Ileana Dumbrava, et al.
Discovery Medicine|March 1, 2015
Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathiesRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine|January 1, 2015
Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndromeRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid MalignanciesAparna Hegde, Priyamvada Jayaprakash, Coline A Couillault, et al.
Pageof 46